# CRISPR screen for cancer dependencies

> A figure of a pooled CRISPR–Cas9 knockout screen for cancer dependencies. A genome-wide sgRNA library is delivered by lentivirus at low multiplicity so each cell carries one guide and loses one gene; the cells grow, and the abundance of each guide is compared early versus late by sequencing. Guides that drop out mark the genes the cancer needs — its dependencies and candidate drug targets.

- Page: https://www.labcanvas.com/templates/cancer-biology/crispr-screen-cancer-dependencies
- Open in the LabCanvas editor (LabCanvas account): https://www.labcanvas.com/editor.html?template=crispr-screen-cancer-dependencies
- Updated: 2026-10-14
- Category: Cancer biology
- Method: Graphical abstract
- Product: The genes a cancer cell depends on, found by knocking out every gene at once
- Key result: Genome-scale screens across hundreds of cancer lines (the Cancer Dependency Map) prioritise therapeutic targets (Tsherniak et al. 2017; Behan et al. 2019)
- Figure: 1920 × 1080 px, 342 editable layers (2 generated objects with settings)

## Steps

1. **Make the library**: A genome-wide library of single-guide RNAs, several guides per gene, is cloned into a lentiviral vector (Shalem et al. 2014; Wang et al. 2014)
2. **One guide per cell**: Cancer cells are transduced at low multiplicity so each cell carries one guide and Cas9 knocks out one gene
3. **Grow & compare**: Cells grow; the abundance of each guide is read by sequencing early (T0) versus late, with or without a drug
4. **Read the dropout**: Guides that deplete mark genes the cancer needs (dependencies); guides that enrich mark genes whose loss gives resistance (Tsherniak et al. 2017)

## Uses

- Functional-genomics review and graphical-abstract figures
- Talks on dependency mapping and target discovery
- Teaching the pooled CRISPR screen workflow

## References

1. Shalem et al., “Genome-scale CRISPR-Cas9 knockout screening in human cells”, Science 2014. https://doi.org/10.1126/science.1247005 (primary)
2. Wang et al., “Genetic screens in human cells using the CRISPR-Cas9 system”, Science 2014. https://doi.org/10.1126/science.1246981 (primary)
3. Tsherniak et al., “Defining a cancer dependency map”, Cell 2017. https://doi.org/10.1016/j.cell.2017.06.010 (primary)
4. Behan et al., “Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens”, Nature 2019. https://doi.org/10.1038/s41586-019-1103-9 (primary)

Credit: Drawn in LabCanvas after Shalem et al., Science 2014 (doi:10.1126/science.1247005); Wang et al., Science 2014 (doi:10.1126/science.1246981); Tsherniak et al., Cell 2017 (doi:10.1016/j.cell.2017.06.010); and Behan et al., Nature 2019 (doi:10.1038/s41586-019-1103-9). The dropout plot is illustrative, not data.

## Questions

**What does the “CRISPR screen for cancer dependencies” template show?** A figure of a pooled CRISPR–Cas9 knockout screen for cancer dependencies. A genome-wide sgRNA library is delivered by lentivirus at low multiplicity so each cell carries one guide and loses one gene; the cells grow, and the abundance of each guide is compared early versus late by sequencing. Guides that drop out mark the genes the cancer needs — its dependencies and candidate drug targets.

**What are the steps shown in “CRISPR screen for cancer dependencies”?** 1. Make the library: A genome-wide library of single-guide RNAs, several guides per gene, is cloned into a lentiviral vector (Shalem et al. 2014; Wang et al. 2014). 2. One guide per cell: Cancer cells are transduced at low multiplicity so each cell carries one guide and Cas9 knocks out one gene. 3. Grow & compare: Cells grow; the abundance of each guide is read by sequencing early (T0) versus late, with or without a drug. 4. Read the dropout: Guides that deplete mark genes the cancer needs (dependencies); guides that enrich mark genes whose loss gives resistance (Tsherniak et al. 2017).

**Which papers is “CRISPR screen for cancer dependencies” based on?** Shalem et al., “Genome-scale CRISPR-Cas9 knockout screening in human cells”, Science 2014 (doi:10.1126/science.1247005); Wang et al., “Genetic screens in human cells using the CRISPR-Cas9 system”, Science 2014 (doi:10.1126/science.1246981); Tsherniak et al., “Defining a cancer dependency map”, Cell 2017 (doi:10.1016/j.cell.2017.06.010); Behan et al., “Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens”, Nature 2019 (doi:10.1038/s41586-019-1103-9).

**Can I edit the “CRISPR screen for cancer dependencies” template?** Yes. Open it in the LabCanvas editor: all 342 layers are editable, including 2 generated objects (structures, plots, equipment) with their own settings. Change the text, colours and layout, then export PNG, TIFF or PDF at the width and DPI the journal asks for.

**Do I need an account to use this template?** Not to view it here. To open and edit it, sign in to LabCanvas or create a free account (the free plan keeps up to 3 designs). Downloading the figure is part of LabCanvas Pro (US$19 a month or US$199 a year).
